The observation of frequent somatic, tumor-specific NF2 mutations, and the loss of the second NF2 allele in schwannomas from patients with germline SMARCB1 mutations10, 57–59 strongly suggest that the classical two-hit model of tumorigenesis does not pertain in the tumors of schwannomatosis patients, as it would require biallelic SMARCB1 inactivation to be sufficient for tumor initiation or growth7. The gene discussed is NF2; the disease is schwannoma.